These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19896954)

  • 1. A mixed two-stage method for detecting interactions in genomewide association studies.
    Zuo Y; Kang G
    J Theor Biol; 2010 Feb; 262(4):576-83. PubMed ID: 19896954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal two-stage strategy for detecting interacting genes in complex diseases.
    Ionita I; Man M
    BMC Genet; 2006 Jun; 7():39. PubMed ID: 16776843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using genome-wide pathway analysis to unravel the etiology of complex diseases.
    Elbers CC; van Eijk KR; Franke L; Mulder F; van der Schouw YT; Wijmenga C; Onland-Moret NC
    Genet Epidemiol; 2009 Jul; 33(5):419-31. PubMed ID: 19235186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.
    Skol AD; Scott LJ; Abecasis GR; Boehnke M
    Nat Genet; 2006 Feb; 38(2):209-13. PubMed ID: 16415888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNPHarvester: a filtering-based approach for detecting epistatic interactions in genome-wide association studies.
    Yang C; He Z; Wan X; Yang Q; Xue H; Yu W
    Bioinformatics; 2009 Feb; 25(4):504-11. PubMed ID: 19098029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive rule inference for epistatic interaction detection in genome-wide association studies.
    Wan X; Yang C; Yang Q; Xue H; Tang NL; Yu W
    Bioinformatics; 2010 Jan; 26(1):30-7. PubMed ID: 19880365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of the relative power of direct and indirect association studies and the implications for their interpretation.
    Moskvina V; O'Donovan MC
    Hum Hered; 2007; 64(1):63-73. PubMed ID: 17483598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal robust two-stage designs for genome-wide association studies.
    Nguyen TT; Pahl R; Schäfer H
    Ann Hum Genet; 2009 Nov; 73(Pt 6):638-51. PubMed ID: 19839987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian inference of epistatic interactions in case-control studies.
    Zhang Y; Liu JS
    Nat Genet; 2007 Sep; 39(9):1167-73. PubMed ID: 17721534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
    Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
    Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting susceptibility genes in case-control studies using set association.
    Kim S; Zhang K; Sun F
    BMC Genet; 2003 Dec; 4 Suppl 1(Suppl 1):S9. PubMed ID: 14975077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide strategies for detecting multiple loci that influence complex diseases.
    Marchini J; Donnelly P; Cardon LR
    Nat Genet; 2005 Apr; 37(4):413-7. PubMed ID: 15793588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal multistage designs--a general framework for efficient genome-wide association studies.
    Pahl R; Schäfer H; Müller HH
    Biostatistics; 2009 Apr; 10(2):297-309. PubMed ID: 19075295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Software engineering the mixed model for genome-wide association studies on large samples.
    Zhang Z; Buckler ES; Casstevens TM; Bradbury PJ
    Brief Bioinform; 2009 Nov; 10(6):664-75. PubMed ID: 19933212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive two-stage analysis of genetic association in case-control designs.
    Zheng G; Song K; Elston RC
    Hum Hered; 2007; 63(3-4):175-86. PubMed ID: 17310127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing gene length biases in gene set analysis of Genome-Wide Association Studies.
    Jia P; Tian J; Zhao Z
    Int J Comput Biol Drug Des; 2010; 3(4):297-310. PubMed ID: 21297229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling interactions with known risk loci-a Bayesian model averaging approach.
    Ferreira T; Marchini J
    Ann Hum Genet; 2011 Jan; 75(1):1-9. PubMed ID: 21118191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers.
    Ohashi J; Tokunaga K
    J Hum Genet; 2001; 46(8):478-82. PubMed ID: 11501946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sum statistics for the joint detection of multiple disease loci in case-control association studies with SNP markers.
    Wille A; Hoh J; Ott J
    Genet Epidemiol; 2003 Dec; 25(4):350-9. PubMed ID: 14639704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for detecting susceptibility genes with weak or no marginal effect.
    Kotti S; Bickeboller H; Clerget-Darpoux F
    Hum Hered; 2007; 63(2):85-92. PubMed ID: 17283437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.